Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Recruiting
N/A
Interventional Study
Pulmonary Fibrosis
Interstitial Lung Disease (ILD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 220 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to evaluate the impact of structurally replacing half of the outpatient clinic visits for patients with pulmonary fibrosis by home monitoring and video consultations on patient self-management and health(care) outcomes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* A multidisciplinary ILD team diagnosis of pulmonary fibrosis according to ATS/ERS/JRS/ALAT guidelines;
* Adults (=/\>18 years).
Exclusion Criteria:
* Patients who are not able to speak, read and/or write in Dutch;
* Patients with no access to the internet;
* Patients with a …
Contacts